- Country: Ukraine
- Summary: Betagistin Tablets of 24 Mg (Betahistine); Dexamethasone, Solution for Injection of 4Mg/Ml (Dexamethasone); Diclofenac Tablets/Capsules of 50 Mg (Diclofenac); Difenhydramine, Injection Solution, 10 Mg/Ml, on ...
- UAT Ref No: 119799876
- Deadline: 29 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 1626366
- Notice Type: Tender
- Document Ref. No.: UA-2025-05-26-002921-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Betagistin tablets of 24 mg (Betahistine); Dexamethasone, solution for injection of 4mg/ml (Dexamethasone); Diclofenac tablets/capsules of 50 mg (diclofenac); Diphenhydramine, injection solution, 10 mg/ml, 1 ml (diphenhydramine); Calcium gluconate solution for injection 100 mg/ml of 10 ml (Calcium gluconate);Captopril/hydrochlortiazide, tablets, 50/25 mg (Captopril and diurets); Ascorbic acid tablets of 500 mg (ASCORBIC ACID (VIT C)); Acetylsalicylic acid tablets of 500 mg (Acetylsalicylic Acid); Magnesium sulfate, injection solution, 250 mg/ml, 5 ml (magnesium sulfate); Meloxicam solutionfor injection 10 mg/ml of 1.5 ml (meloxicam); Pentoxifylline, injection solution, 20 mg/ml, 5 ml (Pentoxifylline); Theophylline solution for injection of 20 mg/ml of 5 ml (theophylline); Terbinafine, cream/gel, 1 %, 15 g (terbinafine); Chloramphenicol/methyluracil ointment 7.5 mg/40 mg for 40 g (Comb drug);Carbon activated tablets/capsules of 250 mg (Medicinal Charcoal); Calcium chloride solution for injection, 100 mg/ml 10 ml (Calcium chloride); Bemiparin sodium solution of 3500 IUs, 0.2 ml (bemiparin) under the code DK 021: 2015-33600000-6 Pharmaceutical products
Procurement type: goods
DK 021: 2015: 33600000-6:Pharmaceutical products
Betagistin tablets of 24 mg, dexamethasone, solution for injection of 4mg/ml, diclofenac tablets/capsules of 50 mg, diphenhydramine, solution for injection, 10 mg/ml, 1 ml, calcium gluconate/mlg. 50/25 mg,Ascorbic acid tablets of 500 mg, acetylsalicylic acid tablets of 500 mg, magnesium sulfate, solution for injection, 250 mg/ml, 5 ml, meloxicam, 10 mg/ml injection solution for 1.5 ml, pentoxifylline, solution for injection, 20 ml, 20 ml. 5 ml,Terbinafine, cream/gel, 1 %, 15 g, chloramphenicol/methyluracil ointment 7.5 mg/40 mg for 40 g, charcoal activated tablets/capsules of 250 mg, calcium chloride solution for injection, 100 mg/ml 10 ml, sodium sodium solution of 3500 IUs.ml - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINBetagistin Tablets of 24 Mg (Betahistine); Dexamethasone, Solution for Injection of 4Mg/Ml (Dexamethasone); Diclofenac Tablets/Capsules of 50 Mg (Diclofenac); Difenhydramine, Injection Solution, 10 Mg/Ml, on ... - Ukraine Tender
The A4615 MILITARY UNIT, a Government sector organization in Ukraine, has announced a new tender for Betagistin Tablets of 24 Mg (Betahistine); Dexamethasone, Solution for Injection of 4Mg/Ml (Dexamethasone); Diclofenac Tablets/Capsules of 50 Mg (Diclofenac); Difenhydramine, Injection Solution, 10 Mg/Ml, on .... This tender is published on UkraineTenders under UAT Ref No: 119799876 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-29.
The estimated tender value is UAH 1626366, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
